OptraSCAN
PrivateLast Round
Series B
Nov 5, 2024
Total Funding Raised
$30M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
OptraSCAN is a medical equipment manufacturing company that provides digital pathology solutions, including slide scanners, AI-based image analysis, and cloud-based storage.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Medical AI, Telemedicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OptraSCAN Comparables
Compare OptraSCAN with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mikroscan Technologies | 85% | |
| MedPrime Technologies | 79% | |
| Morphle Labs | 79% | |
OptraSCAN Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 5, 2024 | ||||
| Series A | Oct 18, 2016 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Launched BactoSiA, an AI-enabled solution for standardizing TB smear microscopy.
- Oct 1, 2025
Now operating in over 30 countries worldwide.
OptraSCAN Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OptraSCAN's valuation, stock price, and market status.